NASDAQ: ELDN
Eledon Pharmaceuticals Inc Stock Ownership - Who owns Eledon Pharmaceuticals?

Insider buying vs selling

Have Eledon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Davidalexandre C. GrosCEO2026-07-31194,791$3.38
$658.39kSell
Steven PerrinPres2026-07-3172,138$3.38
$243.83kSell

1 of 1

ELDN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELDN insiders and whales buy or sell their stock.

ELDN Shareholders

What type of owners hold Eledon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Seth Loring Harrison9.62%8,124,773$14.46MInsider
Erez Chimovits6.77%5,720,424$10.18MInsider
Novartis Bioventures Ltd5.32%4,493,458$8.00MInsider
Apple Tree Partners II LP4.99%4,218,641$7.51MInsider
Apple Tree Partners II Annex LP4.23%3,568,438$6.35MInsider
Muneer A. Satter2.10%1,771,688$3.15MInsider
Lifesci Index Partners LLC1.26%1,065,867$1.90MInsider
Logos Global Management LP0.44%369,071$656.95kInsider
Bvf Partners L P0.26%220,460$392.42kInsider
Martin D. Williams0.20%168,850$300.55kInsider

1 of 3

ELDN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELDN0.05%36.38%Net Selling
PALI0.10%9.16%Net SellingNet Selling
RNA0.07%2.41%Net SellingNet Selling
IFRX0.07%2.95%
VRXA0.00%13.51%Net BuyingNet Buying

Eledon Pharmaceuticals Stock Ownership FAQ

Who owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals (NASDAQ: ELDN) is owned by 0.05% institutional shareholders, 36.38% Eledon Pharmaceuticals insiders, and 63.57% retail investors. Seth Loring Harrison is the largest individual Eledon Pharmaceuticals shareholder, owning 8.12M shares representing 9.62% of the company. Seth Loring Harrison's Eledon Pharmaceuticals shares are currently valued at $14.46M.

If you're new to stock investing, here's how to buy Eledon Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.